Charles A Rowland Jr's Net Worth

Charles A Rowland Jr's net worth is estimated to be at least $3,753,942.47 as of 05/30/2024. CoreStreet's estimation of Charles A Rowland Jr's net worth is based on their sale of stock and current holding of stock.

Charles A Rowland Jr is Director at Viking Therapeutics Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 40,000 units of VKTX stock on 05/16/2023. Their biggest sale was on 12/17/2020 when they sold 10,909 units of Blueprint Medicines Corp stock for $1,285,298.38. They typically trade 1 times per year.

Total value of insider buys:
  • $342,717.07
Total value of insider sells:
  • $3,411,225.40
Most recent insider trade:
  • May 16, 2023

Charles A Rowland Jr's Insider Trading History

Viking Therapeutics IncTitleAmountPriceTypeTotal Value
May 16, 2023
Director40,000$25.00Sell$1,000,000.00
Generation Bio CoTitleAmountPriceTypeTotal Value
Sept. 19, 2022
Director15,750$5.26Buy$82,845.00
Sept. 15, 2022
Director17,147$5.41Buy$92,765.27
Sept. 13, 2022
Director18,784$5.20Buy$97,676.80
Nabriva Therapeutics AGTitleAmountPriceTypeTotal Value
Aug. 1, 2022
Director8,496$0.17Sell$1,444.32
Dec. 24, 2018
Director53,000$1.31Buy$69,430.00
Blueprint Medicines CorpTitleAmountPriceTypeTotal Value
Dec. 17, 2020
Director10,909$117.82Sell$1,285,298.38
June 20, 2019
Director11,818$95.15Sell$1,124,482.70